News | November 11, 2021
Clinical study shows ViroStop spray prevents Covid-19
Evidence also shows better immune response to virus among users of spray
Evidence also shows better immune response to virus among users of spray
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
Barbara Engelhardt moves her computational and statistics lab to Gladstone
The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
9th edition of flagship pharma conference to be held on April 13-14, bringing together policymakers, industry leaders and global stakeholders
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
Subscribe To Our Newsletter & Stay Updated
